1. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma


    Hui Shi et al, 2020, International Journal of Nanomedicine CrossRef
  2. Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases
    Maria Cristina Bonferoni et al, 2020, Pharmaceutics CrossRef
  3. Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing
    Yao Jiang et al, 2022, British Journal of Cancer CrossRef
  4. Exploring the role of Nrf2 signaling in glioblastoma multiforme
    Wireko Andrew Awuah et al, 2022, Discover Oncology CrossRef
  5. HJ22, a Novel derivative of piperine, Attenuates ibotenic acid-induced cognitive impairment, oxidativestress, apoptosis and inflammation via inhibiting the protein-protein interaction of Keap1-Nrf2
    Xiping Yang et al, 2020, International Immunopharmacology CrossRef
  6. Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration
    Siqi Wang et al, 2022, Frontiers in Pharmacology CrossRef
  7. Melatonin Induces Melanogenesis in Human SK-MEL-1 Melanoma Cells Involving Glycogen Synthase Kinase-3 and Reactive Oxygen Species
    Juan Perdomo et al, 2020, International Journal of Molecular Sciences CrossRef
  8. Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
    Karoline Almeida Lima et al, 2023, Biomedicines CrossRef
  9. Melatonin’s Antineoplastic Potential Against Glioblastoma
    Enrico Moretti et al, 2020, Cells CrossRef
  10. Rational design of siRNA-based delivery systems for effective treatment of brain diseases
    Dailin Lu et al, 2024, Pharmaceutical Science Advances CrossRef
  11. Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma
    Edilson Ribeiro de Oliveira Junior et al, 2019, Pharmaceutical Research CrossRef
  12. The association between NRF2 transcriptional gene dysregulation and IDH mutation in Grade 4 astrocytoma
    Maher Kurdi et al, 2023, Oncologie CrossRef
  13. Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin
    Somanathapura K. NaveenKumar et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  14. The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications
    Seyed Hossein Shahcheraghi et al, 2022, Medical Oncology CrossRef